罗格列酮与阿尔茨海默病

被引:16
作者
张旭 [1 ,2 ]
王蓉 [1 ,2 ]
机构
[1] 首都医科大学宣武医院中心实验室北京市老年病医疗研究中心
[2] 教育部神经变性病重点实验室
基金
北京市自然科学基金;
关键词
过氧化物酶体增殖物激活受体γ; 罗格列酮; 阿尔茨海默病; β-淀粉样肽; 炎性反应; 载脂蛋白E;
D O I
暂无
中图分类号
R749.16 [];
学科分类号
摘要
随着人类步入老龄化社会,阿尔茨海默病(Alzheimer's disease,AD)的发病率不断增加,但其发病机制仍不明确,缺乏有效的治疗手段。近年来研究发现AD的患病风险与2型糖尿病具有一定相关性。有证据表明,治疗2型糖尿病的噻唑烷二酮类氧化物酶体增殖物激活受体γ(peroxisome proliferator-activated receptor gamma,PPARγ)激动剂罗格列酮可以改善AD患者和AD动物模型中与此疾病相关的病理变化和学习记忆功能。本文对以上内容和罗格列酮对AD的作用机制进行综述。
引用
收藏
页码:95 / 99
页数:5
相关论文
共 15 条
[1]
Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease [J].
Wahrle, Suzanne E. ;
Jiang, Hong ;
Parsadanian, Maia ;
Kim, Jungsu ;
Li, Aimin ;
Knoten, Amanda ;
Jain, Sanjay ;
Hirsch-Reinshagen, Veronica ;
Wellington, Cheryl L. ;
Bales, Kelly R. ;
Paul, Steven M. ;
Holtzman, David M. .
JOURNAL OF CLINICAL INVESTIGATION, 2008, 118 (02) :671-682
[2]
Rosiglitazone induces mitochondrial biogenesis in mouse brain [J].
Strum, Jay C. ;
Shehee, Ron ;
Virley, David ;
Richardson, Jill ;
Mattie, Michael ;
Selley, Paula ;
Ghosh, Sujoy ;
Nock, Christina ;
Saunders, Ann ;
Roses, Allen .
JOURNAL OF ALZHEIMERS DISEASE, 2007, 11 (01) :45-51
[3]
Synergistic effect of peroxisome proliferator activated receptor-γ and liver X receptor-α in the regulation of inflammation in macrophages [J].
Piraino, Giovanna ;
Cook, James A. ;
O'Connor, Michael ;
Hake, Paul W. ;
Burroughs, Timothy J. ;
Teti, Diana ;
Zingarelli, Basilia .
SHOCK, 2006, 26 (02) :146-153
[4]
Rosiglitazone attenuates learning and memory deficits in Tg2576 Alzheimer mice [J].
Pedersen, Ward A. ;
McMillan, Pamela J. ;
Kulstad, J. Jacob ;
Leverenz, James B. ;
Craft, Suzanne ;
Haynatzki, Gleb R. .
EXPERIMENTAL NEUROLOGY, 2006, 199 (02) :265-273
[5]
Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone - A preliminary study [J].
Watson, GS ;
Cholerton, BA ;
Reger, MA ;
Baker, LD ;
Plymate, SR ;
Asthana, S ;
Fishel, MA ;
Kulstad, JJ ;
Green, PS ;
Cook, DG ;
Kahn, SE ;
Keeling, ML ;
Craft, S .
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2005, 13 (11) :950-958
[6]
The Role of Insulin; Insulin Growth Factor; and Insulin-Degrading Enzyme in Brain Aging and Alzheimer's Disease.[J].Claude Messier;Kevin Teutenberg.Neural Plasticity.2005, 4
[7]
Reduced hippocampal metabolism in MCI and AD - Automated FDG-PET image analysis [J].
Mosconi, L ;
Tsui, WH ;
De Santi, S ;
Li, J ;
Rusinek, H ;
Convit, A ;
Li, Y ;
Boppana, M ;
de Leon, MJ .
NEUROLOGY, 2005, 64 (11) :1860-1867
[8]
Insulin resistance contributes to aberrant stress responses in the Tg2576 mouse model of Alzheimer's disease [J].
Pedersen, WA ;
Flynn, ER .
NEUROBIOLOGY OF DISEASE, 2004, 17 (03) :500-506
[9]
Partial loss-of-function mutations in insulin-degrading enzyme that induce diabetes also impair degradation of amyloid β-protein [J].
Farris, W ;
Mansourian, S ;
Leissring, MA ;
Eckman, EA ;
Bertram, L ;
Eckman, CB ;
Tanzi, RE ;
Selkoe, DJ .
AMERICAN JOURNAL OF PATHOLOGY, 2004, 164 (04) :1425-1434
[10]
Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein E-ε4 allele [J].
Cook, DG ;
Leverenz, JB ;
McMillan, PJ ;
Kulstad, JJ ;
Ericksen, S ;
Roth, RA ;
Schellenberg, GD ;
Jin, LW ;
Kovacina, KS ;
Craft, S .
AMERICAN JOURNAL OF PATHOLOGY, 2003, 162 (01) :313-319